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Abstract
The role of PIP2 in pancreatic beta cell function was examined here using the beta cell line
MIN6B1. Blocking PIP2 with PH-PLC-GFP or PIP5KIγ RNAi did not impact on glucose-
stimulated secretion although susceptibility to apoptosis was increased. Over-expression of
PIP5KIγ improved cell survival and inhibited secretion with accumulation of endocytic vacuoles
containing F-actin, PIP2, transferrin receptor, caveolin 1, Arf6 and the insulin granule membrane
protein phogrin but not insulin. Expression of constitutively active Arf6 Q67L also resulted in
vacuole formation and inhibition of secretion, which was reversed by PH-PLC-GFP co-
expression. PIP2 co-localized with gelsolin and F-actin, and gelsolin co-expression partially
reversed the secretory defect of PIP5KIγ-over-expressing cells. RhoA/ROCK inhibition increased
actin depolymerization and secretion, which was prevented by over-expressing PIP5KIγ, while
blocking PIP2 reduced constitutively active RhoA V14-induced F-actin polymerization. In
conclusion, although PIP2 plays a pro-survival role in MIN6B1 cells, excessive PIP2 production
due to PIP5KIγ over-expression inhibits secretion due to both a defective Arf6/PIP5KIγ-dependent
endocytic recycling of secretory membrane and secretory membrane components such as phogrin
and the RhoA/ROCK/PIP5KIγ-dependent perturbation of F-actin cytoskeleton remodeling.
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Introduction
Phosphatidylinositol-4,5-bisphosphate (PIP2) is a minor cell membrane component that
plays a critical role as a secondary messenger with levels rapidly modified after stimuli such
as growth factors or binding to extracellular matrix (1;2). PIP2 regulates a vast array of
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cellular processes such as remodeling of the actin cytoskeleton (3), vesicle trafficking (4),
and apoptosis (5;6).
Phosphatidylinositol 4-phospha t e 5-kinase I (PIP5KI) catalyses the major cellular route of
PIP2 synthesis. Three isoforms of PIP5KI (α, β and γ) have been cloned from the MIN6
pancreatic beta cell line (7;8). These are regulated by various factors including the small G
protein family Rho (9) and Arf (10), which target each isoform to a specific cellular
localization to produce PIP2 (11). For example, PIP5KIγ is targeted to either focal adhesions
(12) or adherent junctions (13) whereas PIP5KIα is targeted to the nucleus (14).
During actin remodeling, PIP2 binds the N-terminal half of the actin severing protein
gelsolin, inactivating it and causing its release from the severed actin filament thereby
promoting actin polymerization (15). PIP2 can also cause separation of actin monomers from
actin monomer binding proteins, such as cofilin (16), thus enhancing actin nucleation
leading to an overall increase in actin polymerization. As expected, over-expression of
PIP5KI dramatically affects actin cytoskeleton dynamics by inducing stress fiber formation
(17). On the contrary, reducing levels of PIP2 blocks actin assembly and cell motility (18).
PIP2 and PIP5KI also play a role in apoptosis. PIP2 prevents apoptosis by inhibiting the
activation of caspase 3 (19), possibly through the formation of a complex with gelsolin (20).
On the other hand, cleavage inactivation of human PIP5KIα (homolog of murine PIP5Kβ)
by caspase 3 has been shown to promote apoptosis (19). In addition, over-expression of
human PIP5KIα or murine PIP5KIβ is thought to protect cells from apoptosis by either
decreasing caspase 3 activation or promoting phosphorylation of ERK 1/2 (19;21).
PIP2 and the Arf6-dependent regulation of PIP5KI are also implicated in the maintenance of
large dense core vesicle (LDCV) exocytosis from neuroendocrine cells (22-24). PIP2 has
been shown to serve as a recruitment factor for proteins implicated in the priming of
exocytic vesicles in a reconstituted assay (25). In pancreatic beta cells, where glucose
regulates secretion of insulin through an intricate network of signaling pathways, both PIP2
and the PIP5KI isoforms PIP5KIα and γ have been implicated in the maintenance of
regulated secretion (26;27), although the precise mechanism of action has not been
elucidated. Additionally, PIP2 has been extensively implicated in clathrin-dependent
endocytosis as a scaffold for many endocytic proteins (28), with the breakdown of PIP2 by
phosphatases required for the subsequent uncoating of endocytic vesicles (29). These
observations have led to a proposed role for PIP2 in the coordination of membrane fusion
and fission with cytoskeletal assembly, providing a basis for membrane movement (4). PIP2
has also been proposed to play a role in vesicle recapture during kiss-and-run exocytosis by
the recruitment of dynamin and concerted action on actin (30).
In this study, we use the well-differentiated transformed mouse pancreatic beta cell line
MIN6B1 to analyze the role of PIP5KIγ and PIP2 in beta cell survival and insulin secretion,
highlighting the importance of tightly controlled PIP2 levels for the maintenance of beta cell
function and identifying the main signaling pathways responsible for the regulation of the
biological action of this key phospholipid on insulin secretion from pancreatic beta cells.
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Results
The Pleckstrin Homology (PH) domain of phospholipase Cδ (PLCδ) specifically binds to
PIP2 and inhibits its interactions with other proteins (26;31) while allowing for its
subcellular localization. As a first approach to investigate the role of PIP2 in MIN6B1 cells
we used a PH-PLC-GFP fusion protein in order to detect and specifically block PIP2
biological action and PH-mutant-PLC-GFP (or PH-mut-PLC-GFP), a negative control
unable to bind to PIP2 as described by others. As expected, PH-PLCGFP localized to the
plasma membrane of cells, where PIP2 is primarily produced (1;22) (Figure 1A, top left
panel), and co-localized with cortical F-actin (Figure 1A, bottom left panel), while PH-mut-
PLCGFP was detected throughout the cytoplasm (Figure 1A, right panels). We used these
constructs to analyze the impact of modulating availability of PIP2 on the secretory response
to glucose of MIN6B1 cells, using human growth hormone (hGH) as a surrogate marker for
insulin secretion specifically from the population of transfected cells as previously described
(32;33). MIN6B1 cells transfected with PH-PLC-GFP displayed no significant reduction of
glucose-stimulated secretion (fold-stimulation) compared to cells transfected with PH-mut-
PLC-GFP (Figure 1B). On the other hand, when we examined the susceptibility to cell death
by apoptosis, there was a significant increase of TUNEL-positive cells after transfection
with PHPLC-GFP compared to cells transfected with PH-mut-PLC-GFP or with the granule
marker phogrin-GFP, used to monitor transfected cells as described in (34) (Figure 1C).
In order to confirm these results using an alternative strategy, we decreased PIP2 levels by
down-regulating PIP5KIγ using a previously described shRNA expression vector specific
for this kinase (PIP5KI-RNAi) (26). Due to the low level of endogenous PIP5KIγ detected
in MIN6B1 cells (see Figure 2A), these were co-transfected with a plasmid expressing
PIP5KIγ fused to an HA tag (HA-PIP5KI) and either PIP5KI-RNAi or a control non-coding
shRNA expression vector (Control-RNAi) in order to confirm the efficiency of the RNAi to
knock-down PIP5KIγ, and levels of exogenously-expressed PIP5KIγ were analyzed by
western blot with an antibody against the HA tag (Figure 1D). Transfection with PIP5KI-
RNAi resulted in a 60% decrease on PIP5KIγ protein level compared to the control. In
addition, we measured a 43±2.3% drop in the level of PIP5KIγ mRNA by quantitative PCR
in cells expressing PIP5KI-RNAi vs. Control-RNAi (Figure 1E). This reduction was specific
for the γ isoform of the kinase, as the relative mRNA levels of PIP5KI isoforms α and β
were close to 1 (α=1±0.2 and β=0.92±0.04, PIP5KI-RNAi vs. Control-RNAi). Next, we co-
transfected MIN6B1 cells with either PIP5KI-RNAi or Control-RNAi and hGH, and
measured glucose-stimulated secretion. As for cells expressing PH-PLC-GFP, there was no
significant difference in the fold-stimulation of secretion (Figure 1F), indicating that the
partial knockdown of PIP5KIγ does not have a negative impact on secretion. However, we
found a significantly increased susceptibility to apoptosis in cells transfected with PIP5KI-
RNAi compared to Control-RNAi, as shown by TUNEL and caspase 3 activation assays,
with levels of apoptosis comparable to those obtained after gelsolin down-regulation with a
gelsolin-specific shRNA expression vector (Gsn-RNAi) (Figure 1G).
In order to study the impact on secretion and apoptosis of increasing PIP2 levels, MIN6B1
cells were transfected with HA tagged PIP5KIγ (HAPIP5KI), which resulted in a strong
over-expression of the kinase in comparison to control cells (Figure 2A). We then analyzed
Tomas et al. Page 3
Traffic. Author manuscript; available in PMC 2014 July 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
the secretory response to glucose in cells co-transfected with hGH and either HA-PIP5KI or
a control empty vector. HA-PIP5KI-transfected cells presented a blunted secretion compared
to the control resulting in the near complete loss of glucose responsiveness (Figure 2B). On
the other hand, apoptosis (measured as a decrease in TUNEL-positivity) was decreased after
transfection with HA-PIP5KI compared to the phogrin-GFP control (Figure 2C). Given the
striking impairment in secretion caused by over-expression of HA-PIP5KI, we investigated
the phenotype of these cells more closely. Confocal analysis of HAPIP5KI-transfected
MIN6B1 cells revealed the formation of a large number of intracellular vacuoles (Figure 3A;
see also Figures 3C and D). The membrane of these vacuoles contained HA-PIP5KI and
PIP2, and was coated with F-actin.
In order to characterize the importance of the F-actin coat for the formation of the vacuoles,
we incubated cells transfected with HA-PIP5KI or a control empty vector in the presence of
the F-actin depolymerising drug latrunculin B. The vacuoles were still present in HA-
PIP5KI-trasfected cells after latrunculin B treatment, albeit with a modified morphology and
disappearance of the actin coat surrounding them (Figure 3B, micrographs). As previously
described by us (32), glucose-stimulated secretion of MIN6B1 cells was significantly
increased after incubation with latrunculin B, and secretion was decreased in HA-PIP5KI-
transfected cells as for Figure 2B (Figure 3B, bottom). When HA-PIP5KI-trasfected cells
were treated with latrunculin B, glucose-stimulated secretion increased compared to non-
treated HA-PIP5KI-trasfected cells, but the increase in secretion induced by the drug was
lower than that exerted in control cells. Indeed, latrunculin B treatment resulted in 2±0.2-
fold increase in the glucose response of control cells, while it only reached 1.4±0.2 in HA-
PIP5KI-trasfected cells (Figure 3B, bottom).
To characterize the origin of the vacuoles in HAPIP5KI-trasfected cells, we performed a
fluid uptake assay in which we incubated the cells with lysinefixable fluorescently-labeled
dextran prior to fixation. Under these conditions, we could not detect any fluorescent signal
present at the interior of the vacuoles in HA-PIP5KI-trasfected cells (Figure 3C, arrows),
ruling out a macropinocytic origin for the vacuoles. We next performed a transferrin
receptor (TfR) internalization assay in which we cotransfected MIN6B1 cells with HA-
PIP5KI and a TfR expression vector and incubated them in the presence of fluorescent
transferrin before fixation at 0°C or after 30 min incubation at 37°C. As expected, transferrin
labeled the TfR at the cell surface at 0°C (Figure 3D, top, arrow) and was internalized after
30 min incubation at 37°C (Figure 3D, bottom). Transferrin was also incorporated in the
membrane of the vacuoles (Figure 3D, bottom, arrows), indicating that the vacuolar
membrane has, at least in part, a clathrin-dependent endocytic origin. We also detected the
presence of the clathrin-independent endocytic marker caveolin 1 in the vacuolar membrane,
suggesting that both clathrin-dependent and clathrin-independent endocytic pathways
converged in PIP5KIγ over-expressing cells (Figure 3E).
Most of the above-mentioned experiments were based on manipulations of PIP5KIγ
expression levels. In order to confirm that these were actually translated into differences in
the level of intracellular PIP2, we determined the amount of this phosphoinositide in lipid
samples isolated from control MIN6B1 cells or from cells transfected with either PIP5KI-
RNAi or HA-PIP5KI, using a specific PIP2 ELISA test (Figure 4A). Cells displayed a 69%
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reduction in the level of PIP2 compared to the control after PIP5KIγ RNAi, while over-
expression of PIP5KIγ resulted in a 17-fold increase in the amount of PIP2. In an effort to
rule out secondary effects of the variations in PIP2 level on other phosphoinositide species,
we attempted to determine the level of 2 phosphoinositides directly linked to PIP2, namely
PI4P and PIP3, using specific protein-lipid overlay assays. For PI4P, we detected no
differences in cellular levels after transfection with PIP5KI-RNAi or HA-PIP5KI compared
to control cells (Figure 4B), while the level of PIP3 was too low to allow for quantification
in any of the conditions assayed (data not shown). In addition, and in order to rule out
secondary effects of the manipulation of PIP2 levels on the subcellular distribution of the
other phosphoinositide lipids, we performed confocal microscopy analysis of cells co-
transfected with either an empty vector, PIP5KI-RNAi or HAPIP5KI and a set of constructs
expressing protein domains known to bind to specific phosphoinositides fused to fluorescent
markers, widely used for intracellular localization of the different phosphoinositide species
(28) (Figure 4C). As expected, specific detection of PIP2 using the PH domain of PLCδ
showed a reduction in fluorescence at the plasma membrane after transfection with PIP5KI-
RNAi and an increase in fluorescence and accumulation of PIP2-positive vacuoles in
HAPIP5KI-expressing cells. However, neither PIP5KIRNAi nor HA-PIP5KI expression
caused any differences compared to the control in the fluorescence intensity or intracellular
localization of PI3P (using the tandem FYVE domain of Hrs, known to be localized
primarily to endosomes), PI4P (with the PH domain of FAPP1, primarily localized to the
Golgi apparatus) or PIP3 (with the PH domain of Akt, partially localized to the plasma
membrane).
Previous studies have reported that the activation of the small GTPase Arf6 also results in
the accumulation of enlarged PIP2-enriched vacuoles in the cell cytoplasm (10;35) and that
it plays a role in Ca2+-dependent exocytosis by regulating the activity of PIP5KI (23). We
therefore examined the contribution of Arf6 to the formation of PIP5KIγ/ PIP2-induced
vacuoles and its impact on regulated secretion from MIN6B1 cells. First, we cotransfected
MIN6B1 cells with a vector expressing Arf6 fused to a red fluorescent protein (Arf6 wt-
DsRed Monomer) and PH-PLC-GFP for the detection of PIP2. Confocal microscopy
indicated that Arf6 and PIP2 tightly co-localized at the plasma membrane level (Figure 5A),
suggesting that Arf6 may induce the generation of PIP2 by activation of PIP5KI at specific
domains of the plasma membrane. Next, we analyzed the localization of wild type Arf6
(Arf6 wt), constitutively active Arf6 Q67L and dominant negative Arf6 T27N as GFP fusion
proteins in cells over-expressing PIP5KIγ. Both Arf6 wt and Arf6 Q67L localized to the
membrane of HA-PIP5KI-induced vacuoles, while this was much less apparent with
dominant negative Arf6 T27N-GFP (Figure 5B). In addition, Arf6 Q67LDsRed-transfected
cells accumulated F-actin-coated vacuoles similar to the ones found after transfection with
HA-PIP5KI (Figure 5C). We also analyzed the secretory capacity of cells transfected with
the different Arf6 constructs in the presence or absence of PH-PLC-GFP (to block PIP2
protein binding interactions) (Figure 5D). Expression of Arf6 wt-HA or Arf6 Q67L-HA
resulted in significant reductions in the fold-stimulation in secretion induced by glucose, this
phenotype being more drastic for constitutively active Arf6 Q67L-HA and closely
resembling that of PIP5KIγ over-expressing cells. Neither expression of the PIP2 blocking
plasmid PH-PLC-GFP nor dominant negative Arf6 T27N-HA had any effects on the fold-
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increase in secretion of MIN6B1 cells. However, the secretory capacity of cells transfected
with Arf6 Q67L-HA was partially restored by co-expression of PH-PLC-GFP (from 1.7±0.2
to 3.9±0.6 fold-stimulation), and, in parallel, the number of Arf6 Q67L-DsRed-transfected
cells that presented vacuoles was greatly reduced after co-transfection with PH-PLC-GFP
(from 39±3.6% to 7.45±2.4%) (Figure 5E). In addition, and as for transfection with HA-
PIP5K, cells expressing Arf6 Q67L-GFP presented a decrease in apoptosis (measured as a
decrease in TUNEL-positivity) when compared to phogrin-GFP-transfected control cells
(Figure 5F). Taken together, these data suggest that constitutively active Arf6 Q67L is
responsible for over-activation of PIP5KIγ leading to the accumulation of endocytic
vacuoles and a secretion defect in MIN6B1 cells.
To investigate further the phenotype of PIP5KIγ over-expressing cells, we analyzed the
subcellular localization of insulin granules in HA-PIP5KI-transfected MIN6B1 cells by co-
transfection with a construct coding for phogrin fused to GFP, as phogrin is known to reside
in the membrane of insulin granules (36). In addition to its granular localization, we
surprisingly detected phogrin-GFP in the vacuoles of PIP5KIγ over-expressing cells (Figure
6A, top panels), while insulin was excluded from the vacuolar lumen (Figure 6A, bottom
panels). Similar results were found in cells expressing constitutively active Arf6 Q67L-
DsRed, in which phogrin-GFP was localized at the Arf6-induced vacuoles (Figure 6B, left)
whereas neuropeptide Y (NPY) fused to a modified yellow fluorescence protein (NPY-
Venus), used as a surrogate marker for LDCV secretion in living cells (37;38), was excluded
from the vacuole interior (Figure 6B, right). These results suggest the existence of an Arf6/
PIP5KIγ-dependent trafficking pathway implicated in the endocytic recycling of secretory
granule membrane after exocytosis that is blocked at a post-internalization stage in cells
transfected with HA-PIP5KI or Arf6 Q67L. Interestingly, we could observe some instances
in cells cotransfected with phogrin-GFP and Arf6 wt-DsRed (which do not accumulate
vacuoles) in which phogrin-GFP co-localized with the Arf6 wt-specific signal (Figure 6C
top, arrows), but not insulin (Figure 6C, bottom), suggesting the existence of an Arf6-
dependent endocytic recycling pathway through which phogrin would be transported on the
recycling granular membrane following release of insulin.
We previously identified an important role for Ca2+-dependent actin remodeling gelsolin in
the regulation of insulin secretion (32). Given the well established role of PIP2 in gelsolin
inhibition (39), we investigated whether the secretory phenotype observed after over-
expression of PIP5KIγ was, at least in part, dependent on defects in actin cytoskeleton
remodeling due to impaired gelsolin function. First, we analyzed the localization of PIP2, F-
actin and gelsolin in MIN6B1 cells transfected with PH-PLC-GFP. The PIP2-specific signal
co-localized with F-actin at the plasma membrane (Figure 7A, top panels) and with
cytoplasmic gelsolin (Figure 7A, bottom panels). We next analyzed the level of secretion of
MIN6B1 cells co-transfected with hGH and a gelsolin shRNA-expressing vector (Gsn-
RNAi) in conjunction with HA-PIP5KI (Figure 7B, top graph). As we previously reported
(32), gelsolin knockdown resulted in a significant decrease of glucose-stimulated secretion
compared to the control. In addition, co-expression of both Gsn-RNAi and HA-PIP5KI
significantly reduced glucose-stimulated secretion compared to cells transfected with Gsn-
RNAi alone, resulting in the near complete loss of secretory response to glucose. We also
analyzed the level of secretion of cells over-expressing both PIP5KIγ and gelsolin by co-
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expression of HA-PIP5KI and a vector coding for gelsolin fused to an HA tag (HA-Gsn)
(Figure 7B, bottom graph). As expected, HA-PIP5KI-transfected cells displayed markedly
reduced glucose-stimulated secretion compared to the control. Over-expression of gelsolin
partially prevented the decrease in glucose-stimulated secretion of HAPIP5KI-transfected
cells, suggesting that PIP2 inhibition of gelsolin contributes to the secretory loss in cells
over-expressing PIP5KIγ.
As the over-activation of PIP5KIγ by Arf6 seems to be responsible for a defect in the
endocytic recycling of secretory membrane without any obvious impact on the actin
cytoskeleton, we wished to identify other signaling pathways that could be responsible for
the over-activation of PIP5KIγ linked to impaired actin cytoskeleton remodeling. The
RhoA/Rho Kinase (ROCK) pathway is well known to play important roles in act in
cytoskeleton remodeling (40), can act via activation of PIP5KI and PIP2 production (9;41),
and as we have recently shown (42), has an impact on F-actin remodeling and insulin
secretion in primary beta cells. As for Figures 2, 3 and 7, transfection with HA-PIP5KI
resulted in a significant reduction of glucose-stimulated secretion while, in agreement with
our previous results in primary beta cells (42), pre- incubation with the ROCK inhibitors
Y-27632 or H-1152 resulted in a significant increase of secretion compared to control cells
(Figure 8A). This increase was no longer present in cells with both ROCK inhibition and
PIP5KIγ over-expression. Inhibition of the RhoA/ROCK pathway had no impact on the
formation of vacuoles in PIP5KIγ over-expressing cells, as HA-PIP5KI-transfected cells still
accumulated vacuoles after treatment with Y-27632 or H-1152 (Figure 8B). On the other
hand, and as for primary beta cells, ROCK inhibition resulted in increased cortical F-actin
depolymerization with MIN6B1 cells exhibiting shorter actin fibers at the sub-
plasmalemmal level than untreated control cells (Figure 8C).
We next investigated the effects of the over-activation of RhoA on actin cytoskeleton
remodeling in MIN6B1 cells using the plasmid RhoA V14-myc, which codes for a
constitutively active mutant of RhoA fused to a myc tag and has previously been shown to
inhibit regulated secretion in PC12 cells (43). Cells transfected with RhoA V14-myc
presented an abnormally condensed cortical F-actin cytoskeleton compared to untransfected
cells from the same dish, with presence of thick actin fibers that did not remodel in the
presence of glucose (Figure 9A, red arrows). In contrast to Arf6 Q67L, RhoA V14-myc-
transfected cells did not accumulate endocytic vacuoles (data not shown). Conversely,
transfection with Arf6 Q67L-HA did not have any effect on cortical actin while, as already
mentioned above (Figure 5C), it led to the formation of cytoplasmic vacuoles (Figure 9B).
In order to determine if PIP2 was responsible for the defect in actin cytoskeleton remodeling
in cells expressing RhoA V14, we co-transfected MIN6B1 cells with RhoA V14-myc and
PH-PLC-GFP in order to block PIP2 (Figure 9C). These cells presented a cortical actin
cytoskeleton that was less condensed than that of cells transfected with RhoA V14-myc
alone, and was similar to that of untransfected cells from the same dish (Figure 9C, red
arrows; compare to Figure 9A). Taken together, these experiments demonstrate that over-
activation of PIP5KIγ by RhoA/ROCK results in cortical actin cytoskeleton remodeling
defects that impact negatively on regulated secretion. This appears to be separate from the
impact of over-activation of PIP5KIγ by Arf6, which results in impaired secretion due to a
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defect on endocytic recycling of secretory membrane and subsequent trapping of granular
membrane components in abnormal endocytic vacuoles.
Discussion
PIP5KI was first linked to exocytosis in an early screening of cytoplasmic factors required
for ATP-dependent priming in PC12 cells (44). A role for PIP2 was inferred as PIP5KI is
known to use ATP to synthesize this phospholipid. Subsequent studies reported that over-
expression of the pleckstrin homology domain of phospholipase Cδ, which specifically
binds to PIP2 thereby preventing its biological function, reduced Ca2+-dependent exocytosis
in chromaffin cells (22) and glucose-stimulated secretion in the pancreatic beta cell line
INS1E (26). Secretion defects identified in chromaffin cells that had nearly completely lost
PIP2 by over-expressing the PIP2-phosphatase synaptojanin 1 (24) or in PIP5KIγ knockout
mice (45) led to the conclusion that PIP2 stimulates exocytosis by increasing the size of the
readily releasable pool of vesicles due to increased priming. Recent reports have however
pointed out a more complicated role for this phospholipid in regulated LDCV exocytosis. As
well as a positive role in the recruitment of priming factors, PIP2 was shown to inhibit
SNARE-dependent liposome fusion. This inhibition was proposed to be based on its
intrinsic positive membrane curvature-promoting properties as an inverted cone-shaped lipid
(25). In addition, PIP5KI activity and PIP2 levels were shown not to be modulated by
stimulation with secretagogues in PC12 cells (46).
We could not detect any deleterious effect on the secretory capacity of MIN6B1 cells of
reducing the level of active PIP2 by expression of PH-PLC-GFP or by partial knockdown of
PIP5KIγ. We interpret these results as the consequence of a dual (positive and negative) role
of PIP2 in insulin granule exocytosis. Any secretion phenotypes would therefore require
severe inhibition of PIP2 in order to be detected, as we believe that in MIN6B1 cells with a
partial decrease in PIP2 levels, reduced granule priming would be compensated by increased
membrane fusion.
Regardless of these considerations, the present study shows for the first time a clear role of
PIP2 as a pro-survival factor in pancreatic beta cells. Both expression of PH-PLC-GFP and
PIP5KIγ RNAi resulted in increased susceptibility to apoptosis, a phenotype that was
reversed by over-expression of PIP5KIγ with the HA-PIP5KI construct. PIP2 has been
shown to have anti-apoptotic properties due to its capacity to inhibit caspase 3 activity
through the formation of a PIP2-gelsolin-caspase complex (19;20). We have previously
identified gelsolin as an anti-apoptotic protein that blocks activation of caspase 3 in
MIN6B1 and primary beta cells (34). Here we show that PIP5KIγ RNAi results in increased
levels of caspase 3 activation similar to those found after gelsolin RNAi. We therefore
hypothesize that PIP2 plays a role as a pro-survival factor in conjunction with gelsolin by
caspase 3 inhibition in pancreatic beta cells. Further experiments that fall outside of the
scope of this study will be required to confirm this hypothesis.
Aside from a reduction in apoptosis, over-expression of PIP5KIγ resulted in the near
complete abolishment of the secretory response to glucose in MIN6B1 cells. This effect is
different to that found in other neuroendocrine cell types, such as chromaffin cells (24) or
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the PC12 cell line (47), where exogenous expression of murine PIP5KIγ or β, respectively,
potentiated secretion. Intracellular application of PIP2 has been shown to stimulate
exocytosis in pancreatic beta cells (48) and in the beta cell line INS1E (26). However, the
effect of PIP5KIγ over-expression in beta cells has not been investigated before. In this
context, it is worth noting that in the present study transfection with HAPIP5KI resulted in a
vast increase in the amount of PIP5KIγ (taking into account that only ~15% of cells were
transfected and the mixed population of transfected and untransfected cells presented a 6-
fold increase as observed by Western blot) and in a 17-fold increase in the level of PIP2
compared to untransfected cells. This might explain the appearance of a phenotype that
would not be apparent in a less extreme environment or in the special situation of patch-
clamped (48) or streptolysin-O permeabilized cells (26). Under our experimental conditions,
transfection with HAPIP5KI led to the accumulation of PIP2-enriched cytoplasmic vacuoles
that had an endocytic origin. Whether or not similar vacuoles appear in beta cells following
direct application of PIP2 was not documented in the earlier studies (26;48). Similar
vacuoles have been observed in the past after over-expression of mouse PIP5KIβ in 293T
cells (49) and mouse PIP5KIβ or γ in 3T3L1 adipocytes (50), as well as in nerve terminals of
mice lacking the PIP2-phosphatase synaptojanin (29). In agreement with (50), PIP5KIγ-
induced vacuoles resulted from convergence of b o t h c l a t h r i n-dependent and clathrin-
independent endocytosis and were coated with actin. Although disruption of the F-actin coat
increased glucose-stimulated secretion in PIP5KIγ over-expressing cells, the vacuoles were
still present (albeit with a changed morphology) and the increase in the fold-stimulation of
secretion elicited by latrunculin B was proportionally lower to that in control cells. This
indicates that disruption of the F-actin coat is not sufficient to reverse the phenotype
observed in PIP5KIγ over-expressing cells, which must harbor a defect in the trafficking of
endocytic membrane and possibly a reduced capacity in actin cytoskeleton remodeling that
would explain the lower efficiency of latrunculin B in potentiating glucose-stimulated
secretion secretion.
Given that PIP2 plays an important role in the assembly of endocytic vesicles via the
recruitment of essential vesicle coating factors, and that subsequent PIP2 degradation by
phosphatases is required for the uncoating of these vesicles (29;51) we hypothesize that the
over-production of PIP2 in PIP5KIγ over-expressing beta cells may lead to a defect in the
uncoating of endocytic vesicles that results in accumulation of abnormal vacuoles due to a
halt in the endocytic trafficking pathway.
In this regard, we have investigated the role of Arf6 as a candidate GTPase responsible for
the activation of PIP5KIγ specifically to function in the endocytic pathway of MIN6B1
cells. Arf6-GTP (but not Arf6-GDP) has been found to interact with and activate PIP5KIγ in
order to facilitate the assembly of clathrin-coated pits required for the endocytic recycling of
synaptic vesicle membrane (52). We could observe extensive co-localization of Arf6 and
PIP2 in discrete loci at the plasma membrane of MIN6B1 cells. In addition, both Arf6 wt
and constitutively active Arf6 Q67L localized to the membrane of PIP5KIγ-induced
vacuoles, this being much less evident for dominant negative GDP-bound Arf6 T27N. Arf6
Q67L has been shown previously to induce the formation of PIP2-positive actin-coated
endocytic vacuoles that mimic those found after PIP5KI over-expression (10;35). In
agreement with these reports, Arf6 Q67L expression in MIN6B1 cells resulted in the
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accumulation of F-actin-coated vacuoles. More importantly, this was accompanied by a
reduction in the secretory fold-stimulation similar to that found after PIP5KIγ over-
expression, with partial restoration of secretion together with a significant reduction in the
number of vacuole-containing Arf6 Q67L-expressing cells by co-expression of the PIP2-
blocking construct PHPLC-GFP. Conversely, and contrary to a previous report (53),
expression of the dominant negative mutant Arf6 T27N did not have any effect on glucose-
stimulated secretion in MIN6B1 cells.
Arf6 Q67L expression has previously been reported to cause inhibition of Ca2+-dependent
exocytosis and accumulation of PIP5KI and PIP2 on endosomal membranes in PC12 cells
(23). In the cited study exocytosis was restored by co-over-expression of PIP5KIγ, leading
the authors to conclude that the secretory defect was due to the abnormal trapping of PIP5KI
by Arf6 Q67L on endosomes and the subsequent depletion of PIP2 from the plasma
membrane. Our results show a very different picture. In fact, co-over-expression of PIP5KIγ
and Arf6 Q67L in MIN6B1 cells did not lead to any improvement in glucose stimulated
secretion (data not shown), a result somewhat expected by us due to the highly impaired
secretion observed in PIP5KIγ-expressing MIN6B1 cells. We therefore conclude that the
inhibition of secretion observed in MIN6B1 cells is not due to trapping of PIP5KIγ on
endosomes but rather to over-production of PIP2 by either over-expression of PIP5KIγ or
over-activation of PIP5KIγ by Arf6 Q67L.
In this study we have also identified a link between an endocytic trafficking defect and the
secretion impairment observed in PIP5KIγ- or Arf6 Q67L-expressing MIN6B1 cells, namely
the trapping of secretory membrane proteins such as phogrin (but not secretory granule
contents, i.e. insulin) in endocytic vacuoles. Endocytic recycling of secretory membrane and
secretory membrane components following exocytosis is considered to be an important step
in the regulation of glucose-stimulated insulin secretion (30;54-57), perhaps involving a
dynamin-1-dependent recapture process following kiss-and-run exocytosis (30), however the
exact trafficking pathways downstream of this recapture have remained obscure. Here we
show these to involve an Arf6/PIP5KIγ-dependent pathway and highlight its importance for
the correct regulation of insulin secretion in beta cells.
In addition to its role in membrane trafficking, PIP2 can affect actin cytoskeleton dynamics
via the regulation of key factors involved in F-actin remodeling (for a review see (58)). We
have previously shown that the Ca2+- and PIP2-dependent actin severing protein gelsolin
plays an important role in regulated secretion from MIN6 cells, likely through F-actin
remodeling (32). Gelsolin activity and F-actin remodeling following a glucose-dependent
rise in intracellular Ca2+ are thus required to maintain optimal levels of insulin secretion.
Here we show that the defect in secretion due to the overproduction of PIP2 is further
accentuated by down-regulating gelsolin and on the other hand is partially rescued by
gelsolin over-expression. Given this and the tight co-localization of PIP2, gelsolin and F-
actin at the plasma membrane of MIN6B1 cells, we conclude that increased inhibition of
gelsolin by PIP2 is partially responsible for the negative impact of excess PIP2 on insulin
secretion.
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We have recently published a study showing a positive effect of inhibition of RhoA/ROCK
signaling pathway on insulin secretion linked to increased F-actin remodeling (42). Based on
this and on previous studies revealing an intimate crosstalk between this GTPase, PIP2 and
actin we have analyzed the role of this pathway in the activation of PIP5KIγ to function in
F-actin dynamics. We now establish that MIN6B1 cells display an analogous response to rat
primary beta cells after short-term inhibition of ROCK, resulting in increased glucoses t i m
u l a t e d s e c r e t i o n a n d c o r t i c a l F-actin depolymerization. Inhibition of ROCK in
conjunction with over-expression of PIP5KIγ leads to the loss of the positive effect of
ROCK inhibition on secretion but has no effect on the accumulation of vacuoles driven by
excessive PIP2 production. Conversely, constitutive activation of RhoA, known to have a
negative impact on regulated secretion (43), results in increased F-actin polymerization but
does not lead to the accumulation of endocytic vacuoles as for constitutively active Arf6. In
addition, the defect on F-actin remodeling exhibited by constitutively active RhoA-
expressing cells can be (partially) rescued by blockage of PIP2 with PH-PLC-GFP. All of
these data suggest that RhoA/ROCK signaling pathway activity contributes to the over-
activation of PIP5KIγ (and consequently over-production of PIP2) resulting in a negative
impact in the capacity of cells to remodel their actin cytoskeleton in response to glucose,
most probably due to an excessive inhibition of actin remodeling proteins such as gelsolin
by PIP2.
In conclusion, we show for the first time that PIP2 plays a pro-survival role in MIN6B1
cells. However, protection against apoptosis granted by excess PIP2 due to PIP5KIγ over-
expression is associated with a very negative impact on regulated secretion. The inhibition
of secretion results from a halt in the Arf6/PIP5KIγ-dependent endocytic recycling of
secretory membrane and secretory membrane components such as phogrin, and by the
perturbation of F-actin remodeling due to the RhoA/ROCK/PIP5KIγ-dependent inhibition of
actin remodeling proteins such as gelsolin by PIP2.
These results highlight the importance of maintaining tightly controlled PIP2 levels for the
regulation of beta cell function under physiological conditions, as this phospholipid is
implicated in beta cell survival and in the control of two important processes for insulin
secretion (in addition to its reported effects on granule priming and fusion), namely actin
cytoskeleton remodeling and the endocytic recycling of secretory membrane.
Materials and Methods
Reagents and Antibodies
Latrunculin B and the ROCK inhibitors H-1152 and Y-27632 were purchased from
Calbiochem (San Diego, CA) and used at 10 μM, 10 μM and 50 μM, respectively. DNA was
stained with Draq5™ from Biostatus Ltd. (UK) and F-actin was visualized using phalloidin-
AlexaFluor 546 and phalloidin-AlexaFluor 647, from Invitrogen (Carlsbad, CA). The PH-
FAPPYFP construct was obtained from The Division of Signal Transduction Therapy,
University of Dundee, UK. Primary antibodies were mouse anti-HA tag from Roche (Basel,
Switzerland); rabbit anti-cleaved caspase-3 and mouse anti-myc tag from Cell Signaling
Technology (Danvers, MA); mouse anti-PIP5Kγ and rabbit anti-caveolin 1 from BD
Biosciences (Franklin Lakes, NJ); rabbit anti-gelsolin (a gift from Dr. C. Chaponnier,
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University of Geneva Medical School, Switzerland); mouse anti-actin from Chemicon
International (Temecula, CA); and guinea pig anti-insulin (from Dr. D. Bosco, University of
Geneva Medical School, Switzerland). Secondary antibodies were sheep anti-mouse HRP
and donkey anti-rabbit HRP from Amersham Biosciences (Uppsala, Sweden); and goat anti-
mouse AlexaFluor 488, donkey anti-rabbit AlexaFluor 555, donkey anti-mouse AlexaFluor
555, and goat anti-guinea pig AlexaFluor 488 from Invitrogen.
MIN6B1 Cell Culture Conditions
MIN6B1 cells were cultured in DMEM supplemented w i t h 1 5 % F C S , 2 5 m M g l u c o
s e , 7 1 μ M 2-mercaptoethanol, 2 mM glutamine, 100 U/ml penicillin and 100 mg/l
streptomycin at 37°C in an atmosphere of humidified air (95%) and CO2 (5%) as previously
described (59). In general, cells up to passage 25 were sub-cultured into 35 mm wells to
~80% confluency before the experiments. For confocal microscopy cells were plated onto
35-mm glass bottom micro-well dishes (MatTek, Ashland, MA, USA) coated with
extracellular matrix from 804G rat bladder carcinoma cells to favor cell attachment (60).
Transient Transfections
Cells were transfected using Lipofectamine™ 2000 (Invitrogen) according to the
manufacturer's instructions. Transfected cells were incubated for 48 h to allow for construct
expression or 72 h for RNAi.
Growth Hormone Secretion Assays
To study secretion from transfected cells only, cells were co-transfected with the hGH-
expressing vector pcDNA3-hGH and the vector of interest (1:3 DNA ratio). After 48-72 h
cells were analyzed for hGH release, which was used as a surrogate marker for insulin
secretion only from co-transfected cells (61). To this end, co-transfected cells were washed
twice in a modified Krebs–Ringer bicarbonate HEPES buffer [KRBH: 125 mM NaCl, 4.74
mM KCl, 1 mM CaCl2, 1.2 mM KH2PO4, 1.2 mM MgSO4, 5mM NaHCO3, 25 mM HEPES
(pH 7.4) and 0.1% BSA] with 2.8 mM glucose and pre-incubated in this same buffer for 2 h
at 37°C. Cells were then incubated for 1 h at 37°C in KRBH with 2.8 mM glucose (basal
condition), followed by 1 h incubation with KRBH + 16.7 mM glucose (stimulated
condition). Cells were extracted with acid-ethanol, and the amount of growth hormone in the
incubation buffers and cell extracts was measured with the hGH ELISA kit from Roche
Diagnostics (Basel, Switzerland), following the manufacturer's instructions. Growth
hormone secretion is expressed as a percentage of the total growth hormone content, which
is the sum of growth hormone contained in the buffers and cell extracts.
TUNEL and Caspase-3 Activation Assays
Transfected MIN6B1 cells were incubated for 24 h in standard conditions (25 mM glucose;
15% FCS) before inducing apoptosis for 48 h in deprived conditions (5 mM glucose and 1%
FCS). Cells were w a s h e d i n P B S a n d f i x e d w i t h 4 % paraformaldehyde. After
permeabilization with 0.5% Triton X-100 a TUNEL assay, which detects DNA strand
breaks formed during apoptosis (62), was performed using the In Situ Cell Death Detection
Kit ( R o c h e D i a g n o s t i c s ) a c c o r d i n g t o t h e manufacturer's instructions.
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Nuclei were stained with 1 μg/ml Hoechst 33342 and activation by cleavage of caspase-3
was determined by immunofluorescence using an antibody specific for the active cleaved
form of the protein.
Transferrin Receptor Endocytosis Assay
Clathrin-dependent endocytosis was analyzed by TfR internalization assay as described
previously (50). Briefly, MIN6B1 cells were co-transfected with a plasmid encoding human
TfR and with HAPIP5KI. After 48 h, cells were washed and pre-incubated for 1 h in serum-
free DMEM, then chilled on ice and incubated for 30 min with 100 μg/ml AlexaFluor 555-
human transferrin (Invitrogen) to label the surface TfR. After a further 3 washes in ice-cold
serum-free DMEM, 1 dish of cells was fixed in 2 % paraformaldehyde while another dish
was incubated at 37°C for 30 min to allow for transferrin-TfR internalization before fixation.
Both dishes were subsequently processed by immmunofluorescence and confocal
microscopy.
Fluid Phase Uptake Assay
Pinocytosis was assayed by a fluid phase uptake protocol as follows: MIN6B1 cells
previously transfected with HA-PIP5KI were washed in serum-free DMEM and incubated at
37°C for 30 min in 1 mg/ml lysine-fixable Texas Red-dextran 3000 MW (Invitrogen). Cells
were then chilled on ice, washed 3 times with ice-cold serum-free DMEM, fixed and
processed for immunofluorescence and confocal microscopy.
Immunofluorescence and Confocal Microscopy
Cells were washed in PBS, fixed/permeabilized on i c e f o r 3 0 min in 2%
paraformaldehyde supplemented with 0.1% Triton X-100 in PBS, washed again in PBS and
blocked for 15 min with 1% BSA. Fixed cells were incubated with primary followed by
secondary antibody in 1% BSA for 1 h. Cells were observed under a Zeiss LSM 510
inverted confocal microscope using a 63× oil immersion lens. Images were acquired and
processed using the Lsm510 software (Carl Zeiss AG, Germany).
SDS-PAGE and Western Blotting
Cells were washed in PBS and solubilized in lysis buffer (20 mM Tris, pH 7.5, 1 mM
EDTA, 1 mM EGTA, 150 mM NaCl, 1% NP-40) + Complete Mini protease inhibitor
cocktail (Roche, Basel, Switzerland). Lysates were pre-cleared at 16,000 g for 5 min at 4°C,
and total protein levels were quantified using the detergent-compatible protein assay kit
(BioRad, Hercules, CA). Protein samples were re-suspended in SDS-PAGE sample buffer
(62 mM Tris-HCl, pH 6.8, 2% SDS, 5% glycerol, and 1% 2-mercaptoethanol), boiled for 5
min and resolved on a 10% SDS-polyacrylamide discontinuous mini-gel. Proteins were then
electroblotted for 45 min onto a Protran nitrocellulose Transfer Membrane ( S c h l e i c h e r
& S c h u e l l G m b H , G e r m a n y ) . Membranes were treated with blocking solution
(5% skimmed milk in TBS + 0.1% Tween 20) for 1 h at RT, and incubated for 16 h at 4°C
with primary antibody in blocking solution. Following three TBSTween washes, membranes
were incubated with secondary antibody for 90 min in blocking solution. After three more
washes, blots were incubated with the ECL Plus Western blotting detection system
Tomas et al. Page 13
Traffic. Author manuscript; available in PMC 2014 July 09.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
(Amersham Biosciences) and exposed onto BioMax MR Films (Kodak, Rochester, NY).
The films were developed in a Kodak M35 X-OMAT Processor and the resulting bands
were scanned and analyzed with Multi Gauge V3.0 (Fujifilm Life Science, Tokyo, Japan).
Quantitative Real-Time PCR
Cells were co-transfected with pEGFP and either pSUPER-Control RNAi or pSUPER-
PIP5KI RNAi (1:3 DNA ratio). After 72 h, GFP-positive cells were isolated by FACS and
total RNA was extracted with the RNeasy Mini kit (Qiagen, Germany) following the
manufacturer's instructions, and used for cDNA synthesis with Superscript II (Invitrogen)
and Oligo dT primer (Promega, Madison, USA). Specific primers for each of the mouse
PIP5KI isoforms were designed using the Primer Express software, and real-time PCR was
performed using the qPCR core kit for SYBR Green I (Eurogentec, Belgium) in the iCycler
iQ System (BioRad). Relative mRNA expression was normalized with the housekeeping
gene cyclophilin.
Cell Extraction of Phosphoinositides
Transfected cells were trypsinised, counted and pelleted before adding 0.5% ice cold TCA
(1 ml/106 cells). After 5 min incubation on ice, samples were centrifuged at 1500 rpm for 5
min and pellets were washed in 5% TCA + 1 mM EDTA and centrifuged. The neutral lipids
were extracted by vortexing 3 times over 10 min at RT in MeOH:CHCl3 (2:1) followed by
centrifugation. The acidic lipids were also extracted in the same manner by vortexing 4
times over 15 min at RT in MeOH:CHCl3:HCl (80:40:1) at RT followed by centrifugation.
A phase split was performed on the supernatant by adding CHCl3 (0.15 ml/106 cells) + 0.1
M HCl (0.27 ml/106 cells), vortexing and spinning down at 1500 rpm for 5 min. The lower
organic phase was collected and dried in a vacuum dryer. Dried lipids were stored at −20°C
until processed.
Analysis of Phosphoinositide Levels
Phosphoinositide samples were reconstituted, vortexed and sonicated in the appropriate
solution immediately before use. The amount of PIP2 in the purified reconstituted samples
was measured by ELISA using the PI(4,5)P2 Mass ELISA Kit (Echelon Biosciences, Salt
Lake City, USA) according to the supplier's instructions. For PI4P and PIP3 quantifications,
the lipid samples were reconstituted in CHCl3:MeOH:H2O (1:2:0.8) and spotted onto
membranes from the PI4P or the PIP3 Mass Strip Kits (Echelon Biosciences).
Statistics
Data are presented as mean ± SEM for n independent experiments. Statistical significance of
differences between groups was evaluated by Student's unpaired two-tailed t-test with
p<0.05 considered significant.
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Figure 1. Effects of decreasing levels of PIP2 on beta cell survival and insulin secretion
(A) Immunofluorescence analysis of MIN6B1 cells transfected with the PIP2 blocking
vector PH-PLCGFP (lefts panels) or PH-mut-PLC-GFP as a control (right panels). GFP
vectors are depicted in green; F-actin, red (bottom panels); DNA, blue. Bars, 10 μM. (B)
Fold-stimulation of hGH secretion (glucose-stimulated/basal secretion) from MIN6B1 cells
cotransfected with PH-mut-PLC-GFP or PH-PLC-GFP and an hGH-coding vector (used as a
surrogate marker for secretion from transfected cells only). N=9 from 3 independent
experiments. (C) MIN6B1 cells were transfected with phogrin-GFP (control), PH-mut-PLC
or PH-PLC-GFP and apoptosis of GFP-positive cells was measured by TUNEL after 48 h
incubation in deprived conditions. N=4; *p<0.02 vs. phogrin-GFP. (D) Knock-down of
PIP5KIγ by RNAi: MIN6B1 cells were co-transfected with HAPIP5KI and either pSUPER-
Control RNAi or pSUPER-PIP5KI RNAi. After 72 h, expression of HA-tagged PIP5KIγ and
actin (loading control) was examined by Western blot. (E) Quantitative RT-PCR results
showing relative mRNA levels for the 3 mouse PIP5KI isoforms (α, β and γ) in
pSUPERPIP5KIγ RNAi over pSUPER-Control RNAitransfected cells. N=4 from 2
independent experiments, *p<2·10−6. (F) Fold-stimulation in hGH secretion of MIN6B1
cells co-transfected with pSUPER-Control RNAi or pSUPER-PIP5KI RNAi and hGH. N=9
from 3 independent experiments. (G) Apoptosis of GFP-positive MIN6 B1 cells was
measured in deprived conditions by TUNEL (left graph) or active-caspase 3 (right graph) in
cells cotransfected with phogrin-GFP and either pSUPER-Control RNAi, pSUPER-PIP5KI
RNAi or pSUPERGsn RNAi plasmids. N=4, *p<0.04 vs. control RNAi.
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Figure 2. Over-expression of PIP5KIγ protects beta cells from apoptosis but disturbs normal
secretory response to glucose
(A) Western blot analysis of the level of PIP5KIγ and actin (loading control) in MIN6B1
cells transfected with HA-PIP5KI (lane 2) vs. control empty plasmid (Lane 1). (B) Fold-
stimulation of hGH secretion from MIN6B1 cells co-transfected with control empty vector
or HAPIP5KI and hGH. N=9 from 3 independent experiments, *p<5·10−6. (C) Percentage of
apoptotic MIN6B1 cells after transfection with phogrin-GFP (control) or HA-PIP5KI.
Apoptosis specifically from GFP- or HA-positive cells was measured in deprived conditions
by TUNEL. N=3, *p<0.001.
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Figure 3. Over-expression of PIP5KIγ results in the accumulation of PIP2-positive endocytic
vacuoles in the cytoplasm of MIN6B1 cells
(A, top) Immunofluorescence of MIN6B1 cells cotransfected with PH-PLC-GFP (green) and
HAPIP5KI (red). (A, bottom) Immunofluorescence of cells transfected with HA-PIP5KI
showing the vacuoles coated with F-actin. HA-PIP5KI (detected with an anti-HA tag
antibody), green; F-actin, red; DNA, blue. (B, top) F-actin depolymerization affects vacuole
morphology but not vacuole formation: HAPIP5KI-transfected MIN6B1 cells were treated
with latrunculin B for 2 hours prior to fixation. HA-PIP5KI vacuoles are still present (green)
even though F-actin is extensively depolymerized and the vacuoles are no longer actin-
coated (red). (B, bottom) Fold-stimulation of hGH secretion from MIN6B1 cells
cotransfected with hGH and either an empty vector or HA-PIP5KI and pre-treated for 2
hours with DMSO (control) or latrunculin B. N=9 from 3 independent experiments
(*p<6·10−4 and **p<10−6 vs. control DMSO; ***p<0.03 vs. HA-PIP5KI DMSO). (C)
Fluid-phase uptake assay performed in HA-PIP5KI-transfected MIN6B1 cells by incubation
for 30 min with lysine-fixable Texas Red-dextran prior to fixation. HA-PIP5KI is depicted
in green; Texas Red-dextran, red; DNA, blue. (D) TfR internalization assay in vacuole-
containing HA-PIP5KI-transfected MIN6B1 cells co-transfected with a plasmid encoding
human TfR shows that the vacuole membrane has a clathrin-dependent endocytic origin.
HA-PIP5KI is in green; AlexaFluor 555-human transferrin, red; DNA, blue. (E) Clathrin-
independent endocytic membrane also accumulates at PIP5KIγ-induced vacuoles: MIN6B1
cells were transfected with HA-PIP5KI, fixed and labeled by immunofluorescence for
caveolin 1. Note how caveolin 1-positive staining is apparent at the vacuolar membrane (top,
and in a zoomed-in vacuole, bottom). HA-PIP5KI, green; caveolin 1, red in the merged
panel.
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Figure 4. Quantification and subcellular localization of phosphoinositides in MIN6 B1 cells after
PIP5KIγ over-expression and knock-down by RNAi
(A) PIP2 level measured in control untransfected cells and in cells transfected with either
pSUPER-PIP5KI RNAi or HA-PIP5KI. Data has been corrected according to the estimated
transfection efficiency for each plasmid (~70% for pSUPER-PIP5KI RNAi and ~15% for
HA-PIP5KI). N=3-5, *p<0.04 and **p<5·10−7 vs. control. (B) The level of PI4P was
determined in untransfected cells (control −), and in cells transfected with either an empty
vector (control +), HA-PIP5KI or pSUPERPIP5KI RNAi. N=2. (C) Immunofluorescence
analysis of MIN6B1 cells co-transfected with a control empty vector (left panels), pSUPER-
PIP5KI RNAi (central panels) or HA-PIP5KI (right panels; merged, green and red images)
and a series of constructs expressing specific phosphoinositide-recognition domains fused to
GFP or YFP (depicted in green): PH-PLC-GFP (for PIP2 localization), PH-2xFYVE-GFP
(for PI3P localization), PH-FAPP-YFP (for PI4P localization), and PH-Akt-GFP (for PIP3
localization). HA-PIP5KI (detected with an anti-HA tag antibody), red; DNA, blue.
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Figure 5. Arf6-dependent activation of PIP5KIγ results in impaired insulin secretion and
blockage of the endocytic pathway in MIN6B1 cells
(A) MIN6B1 cells were co-transfected with PH-PLC-GFP and Arf6 wt-DsRed Monomer
and basal membranes were observed by confocal microscopy. PH-PLC-GFP, green; Arf6
wt-DsRed Monomer, red; DNA, blue. (B) MIN6B1 cells were co-transfected with HA-
PIP5KI and either Arf6 wt-GFP, Arf6 Q67L-GFP or Arf6 T27N-GFP prior to fixation. HA-
PIP5KI, red; GFP fusion constructs, green; DNA, blue. (C) MIN6B1 cells expressing Arf6
Q67L-DsRed Monomer accumulate similar vacuoles to HA-PIP5KI-expressing cells. Arf6
Q67L-DsRed Monomer, red; F-actin and DNA, blue. (D) Fold-stimulation of hGH secretion
from MIN6B1 cells cotransfected with hGH and a series of constructs including: control
empty vector, PH-PLC-GFP, Arf6 wt-HA, Arf6 Q67L-HA, Arf6 T27N-HA, and a
combination of PH-PLC-GFP and Arf6 wt-HA, Arf6 Q67L-HA or Arf6 T27N-HA
(estimated level of cotransfection ≥95%). N=18 from 6 independent experiments (*p<0.03
and **p<0.0006 vs. control; ***p<0.003 vs. Arf6 Q67L-HA). (E) Percentage of vacuole-
containing cells after transfection with Arf6 Q67L-DsRed Monomer alone or in combination
with PH-PLC-GFP. *p<2·10−6. (F) Percentage of apoptotic MIN6B1 cells after transfection
with phogrin-GFP (control) or Arf6 Q67L-GFP, measured specifically from GFP- positive
cells in deprived conditions by TUNEL. N=4, *p<0.04.
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Figure 6. Endocytic vacuoles accumulated in the cytoplasm of MIN6B1 cells after PIP5KIγ over-
expression or Arf6 over-activation contain the granular membrane protein phogrin but are
devoid of insulin
(A) MIN6B1 cells were cotransfected with HA-PIP5KI and phogrin-GFP. Phogrin was
detected in granules and at the membrane of the vacuoles in PIP5KI-over-expressing cells
(top panels), while insulin (granule cargo) was present in granules but absent from vacuoles
(bottom panels). Phogrin-GFP is in green and HA-PIP5KI, red in the merged top panel;
insulin, green and HA-PIP5KI, red in the merged bottom panel. (B) MIN6B1 cells were co-
transfected with Arf6 Q67L-DsRed Monomer and either phogrin-GFP or NPY-Venus (as a
surrogate marker for granule cargo in living cells), and analyzed by confocal live
microscopy. As for HA-PIP5KI vacuoles, phogrin-GFP (green) is detected at the membrane
of (red) Arf6-positive vacuoles (left panel), while NPY-Venus (green) is excluded from the
vacuolar interior (right panel). (C) MIN6B1 cells were co-transfected with Arf6 wt-DsRed
Monomer and phogrin-GFP. Note some examples of cytoplasmic phogrin-GFP granules
(green) also positive for Arf6 (red) (top panel, arrows) while insulin (green) does not co-
localize with Arf6 (red) (bottom panel).
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Figure 7. Inhibition of the actin-remodeling protein gelsolin in cells with increased level of PIP2
contributes to the reduction of glucose-stimulated insulin secretion
(A) Immunofluorescence analysis of PH-PLC-GFP-transfected MIN6B1 cells. PH-PLC-
GFP, green; F-actin (top panels) and gelsolin (bottom panels), red; DNA, blue. (B) Fold-
stimulation of hGH secretion from MIN6B1 cells co-transfected with hGH and pSUPER-
Control RNAi, pSUPER-Gsn RNAi, or a combination of pSUPER-Gsn RNAi and HA-
PIP5KI (top graph); or pSUPER-Control RNAi, HA-PIP5KI or a combination of HA-Gsn
and HA-PIP5KI (bottom graph). N=15 from 5 independent experiments (top graph:
*p<0.004 vs. control; **p<0.01 vs. pSUPERGsn RNAi; bottom graph: *p<0.04 vs. HA-
PIP5KI; **p<5·10−5 vs. control).
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Figure 8. The Rho-ROCK pathway is implicated in the reduction of glucose-stimulated insulin
secretion due to over-activation of PIP5KIγ via a different mechanism than the Arf6 pathway
(A) Fold-stimulation of hGH secretion from MIN6B1 cells co-transfected with hGH and
either a control empty vector or the HA-PIP5KI plasmid and pre-treated for 2 h with or
without ROCK inhibitors Y-2 7 6 3 2 o r H-1152. N=9 from 3 independent experiments
(*p<4·10−7 and **p<0.02 vs. control; ***p<3·10−5 vs. Y-27632 or H-1152 alone). (B) Cells
were transfected with HA-PIP5KI and treated for 2 h with Y-27632 or H-1152 prior to
fixation. HA-PIP5KI, green; F-actin, red; DNA, blue. (C) MIN6B1 cells were left untreated
or incubated with Y-27632 or H-1152 for 2 h before fixation and confocal microscopy
analysis. The F-actin fibers (stained with fluorescent phalloidin) are shorter in the
cytoskeleton of MIN6B1 cells after treatment with ROCK inhibitors compared to the
control.
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Figure 9. Over-activation of the Rho-ROCK pathway results in disturbance of actin cytoskeleton
remodeling in MIN6B1 cells which is partially counteracted by PIP2 blockage
(A) MIN6B1 cells were transfected with RhoA V14-myc, fixed and analyzed by
immunofluorescence. Note how the F-actin cytoskeleton forms a denser mesh of fibers in
cells expressing RhoA V14-myc (red arrows) than in control untransfected cells from the
same dish. F-actin, red; RhoA V14-myc (detected with an anti-myc tag antibody), green;
DNA, blue in the merged panel. (B) MIN6B1 cells were transfected with Arf6 Q67L-HA.
The same cell is depicted at the basal membrane (upper panels) and at the cell centre (lower
panels). Note how the F-actin cytoskeleton is unchanged in cells expressing Arf6 Q67L-HA
compared to control untransfected neighboring cells, apart from the accumulation of F-actin-
coated Arf6-positive vacuoles. F-actin, red; Arf6 Q67L-HA (detected with an anti-HA tag
antibody), green; DNA, blue in the merged panel. (C) MIN6B1 cells were co-transfected
with RhoA V14-myc and PH-PLC-GFP. Note how cells expressing both constructs (red
arrows) display a less dense actin cytoskeleton than cells transfected with RhoA V14-myc
alone (compare to Figure 8A), resembling that of neighboring untransfected cells from the
same dish. PH-PLC-GFP, green; RhoA V14-myc, red; F-actin, blue in the merged panel.
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